Global medical technology company BD has long included Zufall Health in its philanthropic endeavors. In its most recent contribution, BD has committed $150,000 in funding to Zufall’s mobile medical unit replacement campaign.

SVP of External Affairs and Zufall Health Foundation Director Shade Cronan expressed gratitude: “We appreciate BD for bringing us closer to securing a new mobile medical unit. BD’s generosity is critical to breaking barriers in health care access and transforming lives, particularly for people who cannot easily reach a Zufall site.”

Cronan added that the new vehicle’s exterior will feature BD branding. “The new mobile unit, like the existing one, will regularly visit schools, farms, senior residences, food banks, and other community spaces. The BD name and logo will be visible on the outside of this doctor’s office on wheels.”

Zufall’s relationship with BD dates to its receipt of the inaugural “BD Helping Build Healthy Communities Award” award in 2013. This game-changing donation from BD not only elevated Zufall’s capabilities in diabetes care but helped the health center engage on the national level.

BD has also provided significant funding to ÁNDALE,  Zufall’s nutrition and fitness program for children with obesity, among other initiatives. Given BD’s history of thoughtful and generous support for innovative patient programs, asking BD to take a lead philanthropic role in the mobile unit’s replacement made sense, Cronan said.

BD is enthusiastic about the vehicle as the latest development in its partnership with Zufall. Sien Avalos, Director, Social Investing & Vice President for the BD Foundation, said, “BD is proud to support Zufall Health in their mission to provide access to quality, affordable health care to people and communities who experience barriers to care. Our pledge supports a new mobile medical unit that delivers care to our New Jersey neighbors and furthers our company’s driving purpose which is to advance the world of health. We congratulate Zufall Health on their innovative approach to expand access to those patients who need it most.”